These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 30261314)

  • 1. Establishment of an in vitro cytotoxicity assay platform using primary monkey cardiomyocytes.
    Iguchi T; Fujimoto K; Nakamura S; Kishino H; Niino N; Mori K
    Toxicol In Vitro; 2019 Feb; 54():130-136. PubMed ID: 30261314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening, verification, and analysis of biomarkers for drug-induced cardiac toxicity in vitro based on RTCA coupled with PCR Array technology.
    Zhang L; Xu MX; Yin QS; Zhu CY; Cheng XL; Ren YR; Zhuang PW; Zhang YJ
    Toxicol Lett; 2017 Feb; 268():17-25. PubMed ID: 28099878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment.
    Chaudhari U; Nemade H; Wagh V; Gaspar JA; Ellis JK; Srinivasan SP; Spitkovski D; Nguemo F; Louisse J; Bremer S; Hescheler J; Keun HC; Hengstler JG; Sachinidis A
    Arch Toxicol; 2016 Nov; 90(11):2763-2777. PubMed ID: 26537877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.
    Holmgren G; Synnergren J; Bogestål Y; Améen C; Åkesson K; Holmgren S; Lindahl A; Sartipy P
    Toxicology; 2015 Feb; 328():102-11. PubMed ID: 25529476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of PI3K-Akt through taurine is critical for propofol to protect rat cardiomyocytes from doxorubicin-induced toxicity.
    Sun X; Gu J; Chi M; Li M; Lei S; Wang G
    Can J Physiol Pharmacol; 2014 Feb; 92(2):155-61. PubMed ID: 24502639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutually beneficial relationship between hepatocytes and cardiomyocytes mitigates doxorubicin-induced toxicity.
    Zhang W; Yu J; Dong Q; Zhao H; Li F; Li H
    Toxicol Lett; 2014 Jun; 227(3):157-63. PubMed ID: 24742701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
    Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK
    PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of acute and chronic toxicity of doxorubicin in human induced pluripotent stem cell-derived cardiomyocytes.
    Louisse J; Wüst RCI; Pistollato F; Palosaari T; Barilari M; Macko P; Bremer S; Prieto P
    Toxicol In Vitro; 2017 Aug; 42():182-190. PubMed ID: 28456566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression Profiling of Human Pluripotent Stem Cell-Derived Cardiomyocytes Exposed to Doxorubicin-Integration and Visualization of Multi-Omics Data.
    Holmgren G; Sartipy P; Andersson CX; Lindahl A; Synnergren J
    Toxicol Sci; 2018 May; 163(1):182-195. PubMed ID: 29385562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression.
    Gupta SK; Garg A; Bär C; Chatterjee S; Foinquinos A; Milting H; Streckfuß-Bömeke K; Fiedler J; Thum T
    Circ Res; 2018 Jan; 122(2):246-254. PubMed ID: 29133306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatine supplementation reduces doxorubicin-induced cardiomyocellular injury.
    Santacruz L; Darrabie MD; Mantilla JG; Mishra R; Feger BJ; Jacobs DO
    Cardiovasc Toxicol; 2015 Apr; 15(2):180-8. PubMed ID: 25253560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
    Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvianolic acid B attenuates doxorubicin-induced ER stress by inhibiting TRPC3 and TRPC6 mediated Ca
    Chen RC; Sun GB; Ye JX; Wang J; Zhang MD; Sun XB
    Toxicol Lett; 2017 Jul; 276():21-30. PubMed ID: 28495616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs as potential biomarkers for doxorubicin-induced cardiotoxicity.
    Holmgren G; Synnergren J; Andersson CX; Lindahl A; Sartipy P
    Toxicol In Vitro; 2016 Aug; 34():26-34. PubMed ID: 27033315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts.
    Zhang W; St Clair D; Butterfield A; Vore M
    Toxicol Sci; 2016 May; 151(1):44-56. PubMed ID: 26822305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BN52021 protects rat cardiomyocyte from doxorubicin induced cardiotoxicity.
    Yan W; Xuan C; Xuan L; Xu R; Wang J
    Int J Clin Exp Pathol; 2015; 8(2):1719-24. PubMed ID: 25973059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin protects cardiac myocytes against anthracycline-induced apoptosis.
    Fu P; Arcasoy MO
    Biochem Biophys Res Commun; 2007 Mar; 354(2):372-8. PubMed ID: 17250809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
    Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
    Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of chymotryptic-like standard proteasome activity exacerbates doxorubicin-induced cytotoxicity in primary cardiomyocytes.
    Spur EM; Althof N; Respondek D; Klingel K; Heuser A; Overkleeft HS; Voigt A
    Toxicology; 2016 Apr; 353-354():34-47. PubMed ID: 27155237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.